Aethlon Medical
AEMD
5 hedge funds and large institutions have $185K invested in Aethlon Medical in 2019 Q3 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
0% more funds holding
Funds holding: 5 → 5 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
45% less capital invested
Capital invested by funds: $334K → $185K (-$149K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CFN
Cordasco Financial Network
Naples,
Florida
|
+$52K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$52K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$17.3K |
| 3 |
VF
Virtu Financial
New York
|
-$11K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$9K |
| 5 |
HighTower Advisors
Chicago,
Illinois
|
-$5K |
AEMD Hedge Fund Activity: Q3 2019 in Review
5 of the 4,574 institutional investors tracked by Wall St. Rank reported a position in Aethlon Medical (AEMD) for Q3 2019, worth a combined $185K — down 45% from $334K a quarter earlier.
Fund positioning in AEMD was balanced in Q3 2019: 1 fund opened new positions, 1 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was Cordasco Financial Network, opening a new position worth an estimated $52K. The largest seller was Vanguard Group, cutting an estimated $52K.
- 5 institutional investors held Aethlon Medical (AEMD) as of Q3 2019, unchanged from Q2 2019.
- Funds reported $185K of Aethlon Medical stock for Q3 2019, down 45% quarter-over-quarter.
- 1 fund opened new Aethlon Medical positions in Q3 2019 and 1 closed out, a net change of 0 holders.
- The largest Aethlon Medical buyer in Q3 2019 was Cordasco Financial Network, an estimated $52K added.
- The largest Aethlon Medical seller in Q3 2019 was Vanguard Group, an estimated $52K sold.
Based on aggregated 13F filings for Q3 2019.